Scientific and Medical Advisors

Dr. Lola Reid

FCF strives to be in the forefront of research on fibrolamellar hepatocellular carcinoma. Dr. John Craig and Dr. Lola Reid are the lead medical/scientific advisors for FCF working directly with FCF Scientific Director Mark Furth, PhD.

In addition, listed below are leading physicians, scientists and researchers who deal with fibrolamellar hepatocellular carcinoma and have agreed to be advisors to FCF. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer. It is from this group of advisors, under the guidance of Dr. Craig and Dr. Reid, that FCF puts together committees to review requests for grants.

Ghassan Abou-Alfa, MDAttending Physician
Department of Medicine and Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Nabeel Bardeesy, PhDAssociate Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, MA
Kevin Barry, PhDPostdoctoral Scholar
Department of Pathology
University of California, San Francisco, CA
Michael Choti, MD, MBADivision Chief of Surgery
Banner MD Cancer Center Clinic
Gilbert, AZ
John Craig, MD, PhDPathologist, Director of FCF
Carmel, CA
Ronald DeMatteo, MD, FACSChair, Department of Surgery at Penn Medicine
Head, Division of General Surgical Oncology

Penn Medicine
Philadelphia, PA
Anna Mae Diehl, MDProfessor
Department of Medicine
Duke University
Durham, NC
Ephraim Fuchs, MDProfessor of Oncology and Immunology
Johns Hopkins University
Baltimore, MD
John Gordan, MD, PhDClinical Instructor, Oncology
GI Oncology Group and Shokat Laboratory
University of California, San Francisco, CA
Tim Greten, MDSenior Investigator
Thoracic and Gastrointestinal Oncology Branch
National Cancer Institute
Washington, DC
Yi Guo, PhDAssociate Consultant and Assistant Professor
Biochemistry and Molecular Biology
Mayo Clinic
Rochester MN
Cynthia Guy, MDAssociate Professor
Department of Pathology
Duke University
Durham, NC
William Harris MDAssociate Professor
Division of Oncology
University of Washington School of Medicine
Seattle, WA
Ahmed Kaseb, MDDirector of Hepatocellular Carcinoma Program
Department of Gastrointestinal Medical Oncology
University of Texas M.D. Anderson Cancer Center
Houston, TX
Amy Kim, MDAssociate Professor of Medicine
Division of Gastroenterology/Hepatology
Johns Hopkins University
Baltimore, MD
Olga Kozyreva, MDHematology/Oncology
Dana-Farber Cancer Institute
Boston, MA
Michael LaQuaglia, MD, FACS, FRCSChief, Pediatric Surgical Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Ron Levine, MDInternist
Greenwich, CT
Barbara Lyons, PhDAssociate Professor
Department of Chemistry and Biochemistry
New Mexico State University
Las Cruces, NM
Mark McNiven, PhDGeorge M. Eisenberg Professor
Biochemistry and Molecular Biology
Mayo Clinic
Rochester MN
Sofia de Oliveira, PhDAssistant Professor
Department of Medicine (Hepatology)
Albert Einstein College of Medicine
Bronx, NY
Hibba Tul Rehman, MDChief Fellow
Division of Hematology/Oncology
University of Vermont, Burlington, VT
Lola Reid, PhDProfessor
Department of Cell and Molecular Physiology
University of North Carolina
Chapel Hill, NC
Julien Sage, PhDAssociate Professor
Pediatrics (Hematology/Oncology) and of Genetics

Stanford University
Palo Alto, CA
Praveen Sethupathy, PhDAssociate Professor
Department of Biomedical Sciences
Cornell University College of Veterinary Medicine
Ithaca, NY
Kevin M. Sullivan, MDR3/General Surgery
University of Washington
Seattle, WA
Michael Torbenson, MDSenior Associate Consultant
Department of Anatomic Pathology
Mayo Clinic
Rochester, MN
Jean-Nicholas Vauthey, MDProfessor
Department of Surgical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX
Alan Venook, MDProfessor
Department of Medicine (Hematology/Oncology)
University of California
San Francisco, CA
Yuzhuo Wang, PhDDistinguished Scientist
University of British Columbia Cancer Center
Vancouver, BC